(Q31058006)

28 June 2017

title

Clinical pharmacokinetics of verteporfin (English)

1 reference

28 June 2017

1 reference

Jean-Marie Houle

1

1 reference

28 June 2017

Andrew Strong

series ordinal

2

1 reference

28 June 2017

publication date

1 May 2002

1 reference

The Journal of Clinical Pharmacology

28 June 2017

published in

1 reference

28 June 2017

volume

42

1 reference

28 June 2017

issue

5

1 reference

28 June 2017

page(s)

547-557

1 reference

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

How does photodynamic therapy work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

HPD — A Study of Its Components and Their Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011607

10.1177/00912700222011607

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference